Desk one summarizes the leading findings from the SURPASS systems and particulars the HbA1c lowering efficacy of tirzepatide.Summary Tirzepatide is a whole new molecule effective at controlling glucose blood stages by combining the dual agonism of Glucose-Dependent Insulinotropic Polypeptide (GIP) and Glucagon-Like Peptide-1 (GLP-1) receptors. GIP